KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Acquisitions (2016 - 2023)

CareDx's Acquisitions history spans 8 years, with the latest figure at $2.1 million for Q3 2023.

  • For Q3 2023, Acquisitions rose 317.32% year-over-year to $2.1 million; the TTM value through Jun 2024 reached $2.1 million, down 58.19%, while the annual FY2023 figure was $6.7 million, 995.41% up from the prior year.
  • Acquisitions for Q3 2023 was $2.1 million at CareDx, down from $4.6 million in the prior quarter.
  • Across five years, Acquisitions topped out at $11.9 million in Q4 2021 and bottomed at -$43000.0 in Q2 2021.
  • The 4-year median for Acquisitions is $2.1 million (2019), against an average of $2.8 million.
  • The largest annual shift saw Acquisitions crashed 83.96% in 2019 before it surged 337.21% in 2022.
  • A 4-year view of Acquisitions shows it stood at $111000.0 in 2019, then surged by 10651.35% to $11.9 million in 2021, then plummeted by 95.74% to $508000.0 in 2022, then soared by 317.32% to $2.1 million in 2023.
  • Per Business Quant, the three most recent readings for CDNA's Acquisitions are $2.1 million (Q3 2023), $4.6 million (Q1 2023), and $508000.0 (Q3 2022).